ONC206 not checked
Jazz Pharmaceuticals · JZP3507
FollowEvery change as it happens, and a Monday email
Trials
4 active
4 in total · 1 in the EU
What this is
- How it works
- How it works isn't classified yet
- How it’s given
- “Participants will receive oral JZP3507 monotherapy twice daily, on 3 consecutive days per week in 28-day cycles.”In the company’s words, NCT07533942 on ClinicalTrials.gov
- Tested for
- Meningioma, Advanced Pheochromocytoma and Paraganglioma, PCPG, Central Nervous System Neoplasms, Glioblastoma, Gliosarcoma, Adult, Anaplastic Oligodendroglioma, Anaplastic Astrocytoma and 18 more
- Main trialPhase 2
- “This study will recruit participants with Grade 2 and 3 meningiomas who have failed prior therapy. Participants will receive oral doses of JZP3507. The antitumor activity and safety of JZP3507 will be evaluated.”In the company’s words, NCT07533942 on ClinicalTrials.gov
- Other names
- JZP3507
Other drugs for Meningioma
- ZanzalintinibExelixis · Phase 2
- VMT-α-NETPerspective Therapeutics · Phase 1/2
Coming up3
- 31 Mar 2027Phase 1 trial completes · ClinicalTrials.gov
- 25 Oct 2028Phase 2 trial completes · ClinicalTrials.gov
- 15 Dec 2028Phase 2 trial completes · ClinicalTrials.gov
Changes1
Last 90 days- 9 NovStatus changed: Recruiting to Active, not recruiting · ClinicalTrials.gov NCT04541082
Trials4
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 2Recruiting | 25 Oct 2028 | A Study of JZP3507 (ONC206) in Recurrent Grade 2 or 3 Meningioma | |
| Phase 2Recruiting | 15 Dec 2028 | Study of ONC206 (JZP3507) in Advanced Pheochromocytoma and Paraganglioma | |
| Phase 1Active, not recruiting | 31 Mar 2027 | Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms | |
| Phase 1Authorised | not given | PNOC023: Open Label Phase 1 and Target Validation Study of ONC206 in Children and Young Adults with Newly Diagnosed or Recurrent Diffuse Midline Glioma (DMG), and Other Recurrent Primary Malignant Central Nervous System (CNS) Tumors. |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026